AiCure

Global News

Catalent acquires Micron Technologies

Friday, November 14, 2014 02:19 PM

Catalent, a global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has acquired Micron Technologies, a Boise, Idaho-based global provider of particle size engineering technologies.

More... »


Report: over 6,000 trials conducted in North Carolina since 1999

Friday, November 14, 2014 02:15 PM

Working with institutions in Research Triangle Park and throughout North Carolina, U.S. biopharmaceutical research companies have conducted over 6,000 clinical trials of new medicines in the state since 1999, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »


Precision Therapeutics changes name to Helomics, reorganizes management

Friday, November 14, 2014 10:51 AM

Precision Therapeutics has changed its name to Helomics, a Pittsburgh, Pa.-based, privately held comprehensive personalized healthcare company that develops next-generation diagnostics for the oncology field.

More... »

Parexel opens new European coordination hub and distribution center

Friday, November 14, 2014 10:50 AM

Global CRO Parexel International has opened its new European Coordination Hub and Distribution Center in Berlin-Schönefeld, Germany.  

More... »

EUCROF states position on new clinical trials regulation

Friday, November 14, 2014 10:48 AM

The European CRO Federation (EUCROF), which represents 300 member CROs, has released proposals on the early publication of clinical trial information, balancing the public’s need for transparency and innovators’ intellectual property and confidentiality rights.

More... »

ActiGraph launches GT9X Link activity monitor

Friday, November 14, 2014 10:47 AM

ActiGraph, a Pensacola, Fla.-based provider of objective physical activity and sleep/wake measurement solutions for the global research community and pharmaceutical industry, has released the ActiGraph GT9X Link activity monitor. The redesigned ActiGraph Link expands upon the company’s scientifically validated physical activity and sleep measurement platform with a rich feature set that delivers an improved subject experience along with multiple new channels of sensor data captured by a gyroscope, magnetometer and secondary accelerometer.

More... »

U.K. university, hospital, pharmacy collaborate to improve medicines management

Friday, November 14, 2014 10:45 AM

The first research collaboration in the U.K. among a hospital, university and community pharmacist is taking place through a project from Liverpool John Moores University (LJMU), the Royal Liverpool and Broadgreen University Hospitals NHS Trust and LloydsPharmacy. The collaboration aims to improve the way patients use their medicines outside hospitals and will be carried out in the newly opened Center for Pharmacy Innovation at the LJMU School of Pharmacy and Biomolecular Sciences.

More... »

GHIT Fund calls for greater collaboration on infectious diseases

Friday, November 14, 2014 10:43 AM

The Global Health Innovative Technology (GHIT) Fund and the Embassy of Japan have called for greater cross-border collaboration to ensure global preparedness for the inevitable resurgence of infectious diseases, including tuberculosis, malaria, HIV/AIDS and neglected tropical diseases.

More... »

ArQule, NIH collaborate to develop ARQ 092 in Proteus syndrome

Friday, November 14, 2014 10:39 AM

ArQule, a Woburn, Mass.-based biotech company engaged in the R&D of next-generation, small-molecule cancer therapeutics, has formed an agreement with the National Human Genome Research Institute (NHGRI) of the NIH, providing for the clinical development of ARQ 092, an orally available, selective small molecule inhibitor of AKT, in Proteus syndrome, a rare disease characterized by overgrowth of the skeleton, skin, adipose tissue and central nervous system.

More... »

PRA Health Sciences becomes latest big CRO to launch IPO

Thursday, November 13, 2014 03:38 PM

PRA Health Sciences launched its initial public offering this morning, raising $306 million from the sale of nearly 17 million shares at $18 per share—below plans it announced in September to raise up to $375 million.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs